PBS Biotech, Inc.
Camarillo, CA · CIK 0001962718 · Medtech · Private
Single-use bioreactors for cell-based therapy manufacturing
pbsbiotech.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $43M
- 2 Form D · Sep 2024
- 24 months since last filing
- Contracts
- $224K
- 1 award · Health and Human S
- #451 of 4531 in medtech
- Patents
- 40
- 6 granted · 34 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Intergrated Continuous Biomanufacturing System | $223,699 | |
| Private capital raised | Form D · SEC | $34,706,776 | |
| Private capital raised | Form D · SEC | $8,499,999 |
Federal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 448 | DETON CORP | $225K | — |
| 449 | NANOHYBRIDS INC | $225K | — |
| 450 | XILIS INC | $225K | $109M |
| 451 | PBS Biotech, Inc. | $224K | $43M |
| 452 | NIGHTWARE, INC | $213K | $2.5M |
| 453 | NEW SCALE TECHNOLOGIES, INC | $207K | $784K |
| 454 | Aegis Spine, Inc. | $206K | $1.1M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Nelson BermudezExecutive Officer
- Matt CroughanExecutive Officer
- Dennis FentonDirector
- Leland fosterDirector
- Leland FosterDirector
- Daniel FriedmanDirector
- Brian LeeDirector · Executive Officer
- Xiaoshen LiaoDirector
- Xiaoshen (Jerry) LiaoDirector
- Jung LimDirector
- Terrell MathewsExecutive Officer
- Bryan PoltiloveDirector
Patents
- Material Transfer Devices And Related Systems And Methodsapplication
- Material Transfer Devices And Related Systems And Methodsgranted
- Apparatus And Methods For Treating Media In Large-scale Bioreactorsapplication
- Multi-level Port Vessel For Use In Bioreactor Systemsapplication
- Systems And Methods For Expansion And Differentiation Of Therapeutic Cells In Bioreactorsapplication
- Systems And Methods For Scalable Manufacturing Of Therapeutic Cells In Bioreactorsapplication
- Methods Of Mixing And Dispensing Cellsapplication
- Macrocarriers For Cell Growth In Bioreactorsapplication
- Control Of Cell Growth And Aggregate Size In Bioreactorsapplication
- Homogeneous Cell Dispensing Mixergranted
- In-situ Cell Retention Perfusion Bioreactorsapplication
- Vertical Wheel Bioreactorsgranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.